In hematopoietic stem cell transplantation (HSCT), the outcome is predicted using HLA-matching procedures, which are very time-consuming. There exists substantial evidence of the importance of early donor acceptance in HSCT outcome. In cases when the donor cannot be perfectly matched, it often is unclear which mismatch is less harmful and thus has a greater likelihood of acceptance. We modeled and analyzed interactions between the protein products of different HLA alleles of the transplant recipient and natural killer and T lymphocyte cell receptors of the donor's immune system. Reactions between these 2 systems often lead to graft-versus-host disease (GVHD). Sequence polymorphisms that define HLA I and II alleles predict not only GVHD, but...
AbstractHLA matching between the donor and recipient improves the success of unrelated hematopoietic...
Donor T-cell mediated graft versus host (GVH) effects may result from the aggregate alloreactivity t...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
In hematopoietic stem cell transplantation (HSCT), the outcome is predicted using HLA-matching proce...
HLA polymorphism remains a major hurdle for hematopoietic stem cell transplantation (HSCT). In 2004,...
HLA compatibility is a key factor for survival after unrelated hematopoietic stem cell transplantati...
This report addresses the concept that permissible HLA mismatching, that is, mismatches that do not ...
AbstractPolymorphisms in genes that encode antigen-presenting molecules, antigen receptors, and immu...
Human leukocyte Antigen (HLA) mismatching leads to severe complications after solid-organ transplant...
AbstractThis report addresses the concept that permissible HLA mismatching, that is, mismatches that...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplanta...
We determined whether assessment of the immunogenicity of individual donor-recipient HLA mismatches ...
AbstractHLA matching between the donor and recipient improves the success of unrelated hematopoietic...
Donor T-cell mediated graft versus host (GVH) effects may result from the aggregate alloreactivity t...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
In hematopoietic stem cell transplantation (HSCT), the outcome is predicted using HLA-matching proce...
HLA polymorphism remains a major hurdle for hematopoietic stem cell transplantation (HSCT). In 2004,...
HLA compatibility is a key factor for survival after unrelated hematopoietic stem cell transplantati...
This report addresses the concept that permissible HLA mismatching, that is, mismatches that do not ...
AbstractPolymorphisms in genes that encode antigen-presenting molecules, antigen receptors, and immu...
Human leukocyte Antigen (HLA) mismatching leads to severe complications after solid-organ transplant...
AbstractThis report addresses the concept that permissible HLA mismatching, that is, mismatches that...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplanta...
We determined whether assessment of the immunogenicity of individual donor-recipient HLA mismatches ...
AbstractHLA matching between the donor and recipient improves the success of unrelated hematopoietic...
Donor T-cell mediated graft versus host (GVH) effects may result from the aggregate alloreactivity t...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...